×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [2]
Faculty of Scien... [1]
Authors
KWOK HANG FAI [2]
TAM KAM WENG [1]
CHOI WAI WA [1]
ZHAO QI [1]
Document Type
Journal article [2]
Conference paper [1]
Date Issued
2024 [1]
2022 [1]
2012 [1]
Language
英語English [3]
Source Publication
2012 IEEE Asia-P... [1]
Cellular and Mol... [1]
International Jo... [1]
Indexed By
SCIE [2]
CPCI-S [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer
Journal article
Li, Junnan, Assaraf, Yehuda G., Zuo, Weimin, Lin, Ziqi, Leong, Ka Weng, Zhao, Qi, Zhu, Lipeng, Kwok, Hang Fai. Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer[J]. International Journal of Biological Sciences, 2024, 20(8), 3028-3045.
Authors:
Li, Junnan
;
Assaraf, Yehuda G.
;
Zuo, Weimin
;
Lin, Ziqi
;
Leong, Ka Weng
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
8.2
/
8.3
|
Submit date:2024/07/04
Cancer Therapy
Drug Resistance
Lung Cancer
Reactive Oxygen Species (Ros)
Zeolitic Imidazolate Framework-8 (Zif-8)
Zn2++++
A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis
Journal article
Li, Junnan, Chen, Pengchen, Wu, Qiushuang, Guo, Libin, Leong, Ka Weng, Chan, Kin Iong, Kwok, Hang Fai. A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis[J]. Cellular and Molecular Life Sciences, 2022, 79(12), 614.
Authors:
Li, Junnan
;
Chen, Pengchen
;
Wu, Qiushuang
;
Guo, Libin
;
Leong, Ka Weng
; et al.
Favorite
|
TC[WOS]:
7
TC[Scopus]:
6
IF:
6.2
/
7.7
|
Submit date:2023/01/30
Antibody Therapy
Cell Death
Drug Target
Precision Oncology
Small Molecule
Tunable defected ground structure and its applications to simultaneous reconfigurable communication and partial discharge detection
Conference paper
Chon Chio Leong, Ka Fai Chang, Wai Wa Choi, Kam Weng Tam. Tunable defected ground structure and its applications to simultaneous reconfigurable communication and partial discharge detection[C]:IEEE COMPUTER SOC, 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA, 2012, 159-160.
Authors:
Chon Chio Leong
;
Ka Fai Chang
;
Wai Wa Choi
;
Kam Weng Tam
Favorite
|
TC[WOS]:
0
TC[Scopus]:
1
|
Submit date:2019/02/13